Publications by authors named "Elizabeth Fox"

Claim this Profile
V
Views from chief veterinary officers about decision making during animal health emergencies: A qualitative analysis.
Yrjö T Gröhn, Guillaume Lhermie, Dirk Pfeiffer, Gregorio Torres, Elizabeth L Fox

Prev Vet Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of multi-criteria decision analysis techniques and decision support framework for informing arbovirus risk assessments for planning, preparedness and response.
Segaran P Pillai, Elizabeth Fox, Ann M Powers, Stephen A Morse

Front Bioeng Biotechnol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritizing food systems interventions to reduce adolescents' nutrition insecurity and malnutrition in low-income settings: protocol for the Dishi Fiti Ishi Fiti (Eat Well Live Well) mixed-methods study.
Gwenyth O Lee, Benjamin Jj McCormick, Wiktoria Staromiejska, Vincent Mutuku, Elizabeth L Fox

BMJ Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Sarah Scollon, Sharon E Plon, Steven Joffe, Jaclyn A Biegel, Shashikant Kulkarni, Elizabeth Fox

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial.
Patrice Severe, Samuel Pierre, Fabienne Homeus, Jean Bernard Marc, Letizia Trevisi, Elizabeth Fox

Lancet HIV· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration.
Andrew Dj Pearson, Susan Chi, Theodore W Laetscht, Lynley Marshall, Elizabeth Raetz, Elizabeth Fox

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, Gregory K Friedman, James M Croop

Pediatr Blood Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging Silos: Aligning State Health Improvement, Aging, and Dementia Plans.
Elizabeth Woods Fox, Talyah Sands Leavitt, Tyrone J Bethune, Meghan Fadel

J Public Health Manag Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for Breast Cancer Survivorship Programs Among Multiracial and Ethnic Women.
Lisa Anderson, Oindrila Bhattacharyya, Akia Clark, Sharnell Smith, Michael Grimm, Elizabeth Fox

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial.
Adam L Green, Charles G Minard, Xiaowei Liu, Stephanie L Safgren, Kerice Pinkney, Elizabeth Fox

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions.
Ami V Desai, Aditi Bagchi, Amy E Armstrong, Cornelis M van Tilburg, Ellen M Basu, Elizabeth Fox

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory quality management system fundamentals.
Segaran P Pillai, Elizabeth Fox

Front Bioeng Biotechnol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Food Environment Toolbox: Developing and Piloting a Suite of Tools to Measure Food Environments in Low- and Middle-Income Countries.
Shauna M Downs, Wiktoria Staromiejska, Neha Bakshi, Serey Sok, Nyda Chhinh, Elizabeth L Fox

Curr Dev Nutr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823).
Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, David Hall, Donald A Barkauskas, Elizabeth Fox

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.
Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, Nirali N Shah, André Baruchel, Elizabeth Fox

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A metric of team multitasking throughput.
Elizabeth L Fox, August Capiola, Gregory Bowers, Arielle Stephenson

J Exp Psychol Appl· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Sabine Mueller, Mariella G Filbin, Jacques Grill, Cynthia Hawkins, Elizabeth Fox

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustainability considerations are not influencing meat consumption in the US.
Shauna M Downs, Emily V Merchant, Joachim Sackey, Elizabeth L Fox, Claire Davis

Appetite· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for breast cancer survivorship programs among multiracial and ethnic women.
Lisa Anderson, Oindrila Bhattacharyya, Akia Clark, Sharnell Smith, Michael Grimm, Elizabeth Fox

Res Sq· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514.
Stuart L Cramer, Alyssa Terry Reddy, Charles Gene Minard, Stephan Voss, Elizabeth Fox

Cancer Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615).
Jennifer H Foster, Joel M Reid, Charles Minard, Sarah Woodfield, Kristina Z Denic, Elizabeth Fox

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.
Theodore W Laetsch, Kathleen Ludwig, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Elizabeth Fox

JCO Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).
Margaret E Macy, Rajen Mody, Joel M Reid, Jin Piao, Lauren Saguilig, Elizabeth Fox

JCO Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, Teresa de Rojas, Martha Donoghue, Elizabeth Fox

Eur J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Elizabeth Fox

JCO Precis Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis